Search

Author/Creator Ji, Jun Ho

1. A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer. Issue 3 (May 2017)

Authors:
Hwang, In Gyu; Ji, Jun Ho; Kang, Jung Hun; Lee, Hyo Rak; Lee, Hui-Young; Chi, Kyong-Choun; Park, Suk Won; Lee, Su Jin; Kim, Seung Tae; Lee, Jeeyun; Park, Se Hoon; Park, Joon Oh; Park, Young Suk; Lim, Ho Yeong; Kang, Won Ki
Journal:
Journal of geriatric oncology
Issue:
Volume 8:Issue 3(2017)
Page Start:
170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor‐Induced Skin Toxicities. (6th September 2019)

Authors:
Kim, Young Saing; Ji, Jun Ho; Oh, Sung Yong; Lee, Suee; Huh, Seok Jae; Lee, Ji Hyun; Song, Ki‐Hoon; Son, Choon Hee; Roh, Mee Sook; Lee, Gyeong Won; Lee, Jeeyun; Kim, Seung Tae; Kim, Chan Kyu; Jang, Joung Soon; Hwang, In Gyu; Ahn, Hee Kyung; Park, Lee Chun; Oh, So Yeon; Kim, Seong‐Geun; Lee, Sang‐...
Journal:
Oncologist
Issue:
Volume 25:Number 1(2020)
Page Start:
e186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone‐Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single‐Blind, Crossover Phase III Trial. (7th July 2017)

Authors:
Go, Se‐Il; Koo, Dong‐Hoe; Kim, Seung Tae; Song, Haa‐Na; Kim, Rock Bum; Jang, Joung‐Soon; Oh, Sung Yong; Lee, Kyung Hee; Lee, Soon Il; Kim, Seong‐Geun; Park, Lee Chun; Lee, Sang‐Cheol; Park, Byeong‐Bae; Ji, Jun Ho; Yi, Seong Yoon; Lee, Yun‐Gyoo; Yun, Jina; Bruera, Eduardo; Hwang, In Gyu; Kang, Jun...
Journal:
Oncologist
Issue:
Volume 22:Number 11(2017)
Page Start:
1354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019)

Authors:
Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic...
Journal:
Lancet
Issue:
Volume 394:Issue 10212(2019)
Page Start:
1929
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019)

Authors:
Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic...
Journal:
Lancet
Issue:
Volume 394:Issue 10212(2019)
Page Start:
1929
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Issue 1 (January 2021)

Authors:
Goldman, Jonathan W; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Garassino, Marina Chiara; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libo...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 1(2021)
Page Start:
51
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. High‐level expression of Hsp90β is associated with poor survival in resectable non‐small‐cell lung cancer patients. Issue 4 (26th March 2015)

Authors:
Kim, Seok‐Hyun; Ji, Jun Ho; Park, Kyung Tae; Lee, Ji Hyun; Kang, Kyung Woo; Park, Jae Hong; Hwang, Sang Won; Lee, Eun Hee; Cho, Yu Ji; Jeong, Yi Yeong; Kim, Ho‐Cheol; Lee, Jong Deog; Jang, Inseok; Lee, Jong Sil; Lee, Hyoun Wook; Lee, Gyeong‐Won
Journal:
Histopathology
Issue:
Volume 67:Issue 4(2015)
Page Start:
509
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗